High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care
Open Access
- 29 June 2020
- journal article
- research article
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 166, 108291
- https://doi.org/10.1016/j.diabres.2020.108291
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Endocrine and metabolic link to coronavirus infectionNature Reviews Endocrinology, 2020
- Blood glucose levels in elderly subjects with type 2 diabetes during COVID-19 outbreak: a retrospective study in a single centerPublished by Cold Spring Harbor Laboratory ,2020
- COVID-19 and diabetes: Can DPP4 inhibition play a role?Diabetes Research and Clinical Practice, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998-2013: A Retrospective Cohort StudyDiabetes Care, 2018
- Diabetic emergencies — ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemiaNature Reviews Endocrinology, 2016
- Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 InhibitorsDiabetes Care, 2015
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMCNature, 2013
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetesActa Diabetologica, 2009